PT781547E - Formulacao oftalmica a base de hialuronato de sodio para utilizacao em cirurgia ocular - Google Patents
Formulacao oftalmica a base de hialuronato de sodio para utilizacao em cirurgia ocularInfo
- Publication number
- PT781547E PT781547E PT96120457T PT96120457T PT781547E PT 781547 E PT781547 E PT 781547E PT 96120457 T PT96120457 T PT 96120457T PT 96120457 T PT96120457 T PT 96120457T PT 781547 E PT781547 E PT 781547E
- Authority
- PT
- Portugal
- Prior art keywords
- sodium hyaluronate
- formulation
- ophthalmal
- eye surgery
- surgery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT95MI002744A IT1277707B1 (it) | 1995-12-22 | 1995-12-22 | Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare |
Publications (1)
Publication Number | Publication Date |
---|---|
PT781547E true PT781547E (pt) | 2002-09-30 |
Family
ID=11372809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT96120457T PT781547E (pt) | 1995-12-22 | 1996-12-19 | Formulacao oftalmica a base de hialuronato de sodio para utilizacao em cirurgia ocular |
Country Status (10)
Country | Link |
---|---|
US (1) | US5880107A (pt) |
EP (1) | EP0781547B1 (pt) |
JP (1) | JP4146910B2 (pt) |
AT (1) | ATE216221T1 (pt) |
CA (1) | CA2193543C (pt) |
DE (1) | DE69620724T2 (pt) |
DK (1) | DK0781547T3 (pt) |
ES (1) | ES2175020T3 (pt) |
IT (1) | IT1277707B1 (pt) |
PT (1) | PT781547E (pt) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6541460B2 (en) | 1996-08-07 | 2003-04-01 | George D. Petito | Method for use of hyaluronic acid in wound management |
US6368585B1 (en) * | 1997-03-25 | 2002-04-09 | Pharmacia Ab | Opthalmic compositions and methods |
US20030138499A1 (en) * | 1998-12-17 | 2003-07-24 | Shah Mandar V. | Stable surgical irrigating solutions |
US6533769B2 (en) * | 2001-05-03 | 2003-03-18 | Holmen Joergen | Method for use in cataract surgery |
US7820194B2 (en) | 2001-12-21 | 2010-10-26 | Alcon, Inc. | Combinations of viscoelastics for use during surgery |
ITMI20020557A1 (it) * | 2002-03-15 | 2003-09-15 | Acraf | Uso di un sale dell'acido l-ascorbico per preparare una composizione farmaceutica per uso topico oftalmico capace di migliorare il livello d |
US20040167480A1 (en) * | 2003-02-21 | 2004-08-26 | Advanced Medical Optics, Inc. | Administration of multiple viscoelastic solutions with a multi-compartment syringe |
FR2861734B1 (fr) | 2003-04-10 | 2006-04-14 | Corneal Ind | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus |
US20050215516A1 (en) * | 2004-03-29 | 2005-09-29 | Claudio Bucolo | New free-radical scavenger containing viscoelastic composition, methods of use and package |
US20060073184A1 (en) * | 2004-09-29 | 2006-04-06 | Bausch & Lomb Inc. | Viscoelastic composition, methods of use and packaging device with anti-oxidant |
WO2008042441A1 (en) * | 2006-10-03 | 2008-04-10 | Anthrogenesis Corporation | Use of umbilical cord biomaterial for ocular surgery |
BRPI0811784A2 (pt) * | 2007-05-23 | 2011-05-10 | Allergan Inc | colÁgeno reticulado e uso do mesmo |
US8318695B2 (en) * | 2007-07-30 | 2012-11-27 | Allergan, Inc. | Tunably crosslinked polysaccharide compositions |
US8697044B2 (en) | 2007-10-09 | 2014-04-15 | Allergan, Inc. | Crossed-linked hyaluronic acid and collagen and uses thereof |
BRPI0819075A2 (pt) | 2007-11-16 | 2014-10-07 | Vicept Therapeutics Inc | Método para tratar púrpura em um indivíduo e método para diminuir a púrpura em um indivíduo antes de um procedimento cirúrgico |
US8394782B2 (en) * | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having increased longevity |
US8394784B2 (en) * | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having multi-stage bioactive agent delivery |
US20090143348A1 (en) * | 2007-11-30 | 2009-06-04 | Ahmet Tezel | Polysaccharide gel compositions and methods for sustained delivery of drugs |
EP2229180A1 (en) * | 2007-12-27 | 2010-09-22 | D.M.G. Italia Srl | Composition comprising superoxide dismutase and carboxv methyl beta-1,3 glucan |
US8357795B2 (en) * | 2008-08-04 | 2013-01-22 | Allergan, Inc. | Hyaluronic acid-based gels including lidocaine |
AU2009288118B2 (en) | 2008-09-02 | 2014-12-11 | Allergan, Inc. | Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof |
US20100104654A1 (en) * | 2008-10-27 | 2010-04-29 | Allergan, Inc. | Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof |
JP4885245B2 (ja) * | 2009-01-15 | 2012-02-29 | 日本航空電子工業株式会社 | Rdコンバータ及び角度検出装置 |
EP2512492A1 (en) * | 2009-12-14 | 2012-10-24 | University of Massachusetts | Methods of inhibiting cataracts and presbyopia |
US20110171310A1 (en) * | 2010-01-13 | 2011-07-14 | Allergan Industrie, Sas | Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use |
US9114188B2 (en) | 2010-01-13 | 2015-08-25 | Allergan, Industrie, S.A.S. | Stable hydrogel compositions including additives |
US20110172180A1 (en) | 2010-01-13 | 2011-07-14 | Allergan Industrie. Sas | Heat stable hyaluronic acid compositions for dermatological use |
US20110171311A1 (en) * | 2010-01-13 | 2011-07-14 | Allergan Industrie, Sas | Stable hydrogel compositions including additives |
WO2011110894A2 (en) | 2010-03-12 | 2011-09-15 | Allergan Industrie Sas | Fluid composition for improving skin conditions |
PL3078388T3 (pl) | 2010-03-22 | 2019-08-30 | Allergan, Inc. | Usieciowane hydrożele do powiększania tkanek miękkich |
US8883139B2 (en) | 2010-08-19 | 2014-11-11 | Allergan Inc. | Compositions and soft tissue replacement methods |
US8889123B2 (en) | 2010-08-19 | 2014-11-18 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US8697057B2 (en) | 2010-08-19 | 2014-04-15 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US9005605B2 (en) | 2010-08-19 | 2015-04-14 | Allergan, Inc. | Compositions and soft tissue replacement methods |
KR102015676B1 (ko) | 2011-06-03 | 2019-10-21 | 알러간, 인코포레이티드 | 항산화제를 포함하는 피부 충전제 조성물 |
US20130096081A1 (en) | 2011-06-03 | 2013-04-18 | Allergan, Inc. | Dermal filler compositions |
US9393263B2 (en) | 2011-06-03 | 2016-07-19 | Allergan, Inc. | Dermal filler compositions including antioxidants |
US9408797B2 (en) | 2011-06-03 | 2016-08-09 | Allergan, Inc. | Dermal filler compositions for fine line treatment |
US20130244943A1 (en) | 2011-09-06 | 2013-09-19 | Allergan, Inc. | Hyaluronic acid-collagen matrices for dermal filling and volumizing applications |
US9662422B2 (en) | 2011-09-06 | 2017-05-30 | Allergan, Inc. | Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation |
EA201791321A1 (ru) * | 2012-12-19 | 2018-04-30 | Саркоуд Байосайенс Инк. | Составы ингибитора lfa-1 |
AT514540A1 (de) * | 2013-06-18 | 2015-01-15 | Apomedica Pharmazeutische Produkte Gmbh | Ophthalmische Zusammensetzung |
ES2837626T3 (es) | 2013-07-10 | 2021-07-01 | Matrix Biology Inst | Composiciones de hialuronano con alta elasticidad y usos de las mismas |
JPWO2015125921A1 (ja) * | 2014-02-20 | 2017-03-30 | わかもと製薬株式会社 | 保存効力を有する医薬用水性組成物 |
WO2016051219A1 (en) | 2014-09-30 | 2016-04-07 | Allergan Industrie, Sas | Stable hydrogel compositions including additives |
WO2016128783A1 (en) | 2015-02-09 | 2016-08-18 | Allergan Industrie Sas | Compositions and methods for improving skin appearance |
BR112018003031B1 (pt) * | 2015-08-18 | 2023-12-26 | Astellas Institute For Regenerative Medicine | Solução salina de vida útil prolongada, preparação celular, seus usos, método de obtenção e armazenamento de preparação celular, composição farmacêutica e kit |
PT3352766T (pt) | 2015-09-24 | 2022-03-22 | Matrix Biology Inst | Composições de hialuronano de elevada elasticidade e processos para o seu uso |
EP3871682A1 (en) * | 2016-10-14 | 2021-09-01 | i.com Medical GmbH | Method for establishing, restoring, and preserving homeostasis of the ocular surface |
MX2020004922A (es) * | 2017-11-22 | 2020-08-27 | Bausch & Lomb | Composiciones viscoelasticas oftalmicas. |
CN113354757B (zh) * | 2021-06-26 | 2022-04-08 | 上海加新生物科技有限公司 | 一种小分子透明质酸钠的制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4141973A (en) | 1975-10-17 | 1979-02-27 | Biotrics, Inc. | Ultrapure hyaluronic acid and the use thereof |
US5409904A (en) * | 1984-11-13 | 1995-04-25 | Alcon Laboratories, Inc. | Hyaluronic acid compositions and methods |
US4886786A (en) * | 1985-08-01 | 1989-12-12 | Lindstrom Richard L | Additive for irrigation solution or surgical solution |
IL80298A (en) | 1986-10-14 | 1993-01-31 | Res & Dev Co Ltd | Eye drops |
US4920104A (en) * | 1988-05-16 | 1990-04-24 | Medchem Products, Inc. | Sodium hyaluronate composition |
EP0464727B1 (en) * | 1990-06-29 | 1996-01-03 | Santen Pharmaceutical Co., Ltd. | Use of a composition for the preparation of a medicament for debridment of retained lens material |
WO1994007505A1 (en) * | 1991-07-03 | 1994-04-14 | Norpharmco Inc. | Use of hyaluronic acid and forms to prevent arterial restenosis |
JPH06107538A (ja) * | 1992-03-31 | 1994-04-19 | Shiseido Co Ltd | 角膜移植用眼球保存液 |
JPH05310580A (ja) * | 1992-04-30 | 1993-11-22 | Shiseido Co Ltd | 眼内灌流用液剤 |
-
1995
- 1995-12-22 IT IT95MI002744A patent/IT1277707B1/it active IP Right Grant
-
1996
- 1996-12-19 PT PT96120457T patent/PT781547E/pt unknown
- 1996-12-19 AT AT96120457T patent/ATE216221T1/de active
- 1996-12-19 EP EP96120457A patent/EP0781547B1/en not_active Expired - Lifetime
- 1996-12-19 DK DK96120457T patent/DK0781547T3/da active
- 1996-12-19 DE DE69620724T patent/DE69620724T2/de not_active Expired - Lifetime
- 1996-12-19 ES ES96120457T patent/ES2175020T3/es not_active Expired - Lifetime
- 1996-12-20 JP JP34218496A patent/JP4146910B2/ja not_active Expired - Fee Related
- 1996-12-20 US US08/770,331 patent/US5880107A/en not_active Expired - Lifetime
- 1996-12-20 CA CA002193543A patent/CA2193543C/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2193543C (en) | 2006-02-21 |
ES2175020T3 (es) | 2002-11-16 |
IT1277707B1 (it) | 1997-11-11 |
CA2193543A1 (en) | 1997-06-23 |
DE69620724D1 (de) | 2002-05-23 |
DK0781547T3 (da) | 2002-08-12 |
US5880107A (en) | 1999-03-09 |
EP0781547A1 (en) | 1997-07-02 |
JP4146910B2 (ja) | 2008-09-10 |
ATE216221T1 (de) | 2002-05-15 |
ITMI952744A1 (it) | 1997-06-22 |
ITMI952744A0 (pt) | 1995-12-22 |
EP0781547B1 (en) | 2002-04-17 |
DE69620724T2 (de) | 2002-11-21 |
JPH09216826A (ja) | 1997-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT781547E (pt) | Formulacao oftalmica a base de hialuronato de sodio para utilizacao em cirurgia ocular | |
BR0110505A (pt) | Sistemas de lentes oftálmicas | |
LV10688A (lv) | Pretalergisks sastavs oftalmologijai vai deguna slimibam | |
BR9808282A (pt) | Liberação controlada de produtos farmacêuticos na câmara anterior do olho | |
ATE482675T1 (de) | Optisches implantat für die hornhaut | |
BR9407330A (pt) | Solução oftálmica baseada em diclofenaco e tobramicina e formulação oftálmica | |
BR9916358A (pt) | Conjunto de composição para uso em cirurgia intra-ocular, e, kit para uso em cirurgia intra-ocular | |
SE8403090D0 (sv) | Gel for anvendning som glaskroppssubstitut | |
ATE209897T1 (de) | Lagerstabile ophthalmische zusammensetzungen, umfassend diclofenac und ofloxacin | |
AU4128901A (en) | Colored visco-elastic composition | |
ES2071227T3 (es) | Composicion para gotas para los ojos. | |
CA2436269A1 (en) | Artificial tear composition containing a combination of three demulcents | |
AU5446299A (en) | Medicinal compositions for treating eye diseases | |
DK1023077T3 (da) | Ophthalmisk sammensætning | |
BR9712308A (pt) | Inibidor de catarata secundária | |
ES2141843T3 (es) | Utilizacion de amidoaminas en composiciones oftalmologicas. | |
ES2069823T3 (es) | Tratamiento de la hipertension ocular con una combinacion sinergica ocular. | |
BR0115154A (pt) | material viscoelástico transicional não-aspirante para uso em cirurgia | |
DE69100171D1 (de) | Synergistische kombination zur ophthalmischen verwendung. | |
IT1306135B1 (it) | Composizioni oftalmiche per il trattamento delle turbe visivecaratterizzate da ridotta sensibilita' al contrasto. | |
HU9301364D0 (en) | Homo-prostaglandines applicables for treatment of hypertension in eyes | |
AU643772B2 (en) | Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmological use | |
ES1035324Y (es) | Pinza perfeccionada aplicable en microcirugia oftalmologica para la implantacion de lentes intraoculares. | |
DE69113675D1 (de) | Verwendung von Naproxen als Mydriatikum. |